14th Sep 2022 12:11
Bioventix PLC - London-based biotechnology company - Says that it had a slow start to the financial year that ended June 30. Says that it registered an improvement in the second half and anticipates that its trading results as a whole will "likely" be significantly ahead of market expectations. Attributes the improvement to a degree of recovery from the pandemic woes it experienced since early 2020. "We hope that this recovery will prove to be sustained and long-lasting," the company says. Read More
